Internal Medicine, Medical Oncology · Loveland, CO
NPI
1295713899
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2000 N Boise Ave
Loveland, CO, 80538
Phone (970) 810-3894
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
549 services
Medicare patients, 2024
172
Average age 75
Drug cost, 2024
$3.8M
841 prescriptions
Company payments, 2023
$2,055
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel A Shelanski was code 99214 (office e&m - established), 294 times for 134 patients. In total Samuel A Shelanski billed 549 services in 9 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 294 | 134 | $66.64 | $20K |
| 99215 Office E&M - Established | Office | 179 | 69 | $107.47 | $19K |
| 99213 Office E&M - Established | Office | 22 | 22 | $47.37 | $1,042 |
| 99214 Office E&M - Established | Facility | 12 | 12 | $72.66 | $872 |
| 99205 Office E&M - New | Office | 11 | 11 | $141.70 | $1,559 |
By year: 2022 $40K for 500 services; 2023 $53K for 600 services; 2024 $45K for 549 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samuel A Shelanski prescribed most often to Medicare patients was Xtandi (Enzalutamide), with 50 prescriptions and refills. In total Samuel A Shelanski wrote 841 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xtandi Enzalutamide | 50 | 50 | Under 11 | $610K |
| Anastrozole Generic | 47 | 139 | 16 | $897 |
| Brukinsa Zanubrutinib | 46 | 46 | Under 11 | $653K |
| Prednisone Generic | 36 | 50 | 11 | $380 |
| Lenalidomide Generic | 33 | 33 | Under 11 | $534K |
| Orgovyx Relugolix | 29 | 29 | Under 11 | $71K |
| Ondansetron Hcl Generic | 29 | 29 | 24 | $377 |
| Xarelto Rivaroxaban | 26 | 42 | Under 11 | $23K |
| Tamoxifen Citrate Generic | 25 | 73 | Under 11 | $839 |
| Hydroxyurea Generic | 24 | 74 | Under 11 | $1,340 |
| Acyclovir Generic | 23 | 61 | Under 11 | $506 |
| Gabapentin Generic | 22 | 44 | 13 | $294 |
| Oxycodone Hcl Generic | 22 | 22 | Under 11 | $347 |
| Letrozole Generic | 20 | 60 | Under 11 | $506 |
| Abiraterone Acetate Generic | 18 | 18 | Under 11 | $1,859 |
Brand drugs: 288 claims; generic drugs: 553 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Samuel A Shelanski $2,055 ($2,055 in general payments such as food, travel and fees) from 2 companies. The largest payer was Exelixis Inc. with $1,750.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.